Dendritic cells (DCs) play critical roles in initiating and regulating innate immunity as well as adaptive immune responses. However, the role of conventional dendritic cells (cDCs) in concanavalin A (ConA)-induced fulminant hepatitis is unknown. In this study, we demonstrated that depletion of cDCs using either CD11c-diphtheria toxin receptor transgenic mice (DTR Tg) mice or anti-CD11c antibody reduced the severity of liver injury significantly, indicating a detrimental role of cDCs in ConA-induced hepatitis. We elucidated further the pathological role of cDCs as being the critical source of interleukin (IL)-12, which induced the secretion of interferon (IFN)-g by natural killer (NK) T cells. Reconstitution of cDCsdepleted mice with IL-12 restored ConA-induced hepatitis significantly. Furthermore, we determined that NK T cells were the target of DC-derived IL-12, and NK T cells contributed to liver inflammation and injury through production of IFN-g. In summary, our study demonstrated a novel function of cDCs in mediating ConA-induced hepatitis through regulating IFN-g secretion of NK T cells in an IL-12-dependent fashion. Targeting cDCs might provide potentially therapeutic applications in treating autoimmune related liver diseases.
Introduction
Liver diseases, including viral hepatitis, alcoholic liver disease and autoimmune hepatitis, affect millions of people worldwide. The high risk of hepatitis is due in part to the lack of complete understanding of its pathogenesis. T cellmediated immune responses play critical roles in a series of liver diseases, such as viral infections [1] , autoimmune hepatitis (AIH) [2] and alcoholic-related liver diseases [3] . Concanavalin A (ConA)-induced hepatitis is a well-established model for investigating T cell-dependent hepatitis in mice, which involves a series of hepatic cells and proinflammatory cytokines. Interferon (IFN)-g has been known to play an important role in ConA-induced hepatitis [4, 5] ; in addition, CD4 1 
T cells and natural killer (NK) T cells have been
shown to be implicated in the pathogenesis [6] [7] [8] .
As critical regulators of both innate and adaptive immunity, DCs play important roles in immune responses [9] [10] [11] .
DCs are heterogeneous, differing in origin, location, function and migratory pathways [12] . Infections or inflammatory stimuli can also affect their function and generation [13] . Conventional dendritic cells (cDCs) are a DC subset with a dendritic form and exhibit DC functions in steady state. Predendritic cells (pre-DCs) are cells with the capacity to develop into DCs, including plasmacytoid dendritic cells (pDCs) and monocytes [13] . cDCs account for 1% of hepatic non-parenchymal cells (NPC). Due to the relative scarcity of hepatic DC in normal mice, investigations have been limited. To investigate the role of cDCs, a conditional diphtheria toxin (DT)-based cDCs depletion was generated in mice. Transgenic mice expressed the primate DT receptor (DTR) under the control of the DC-specific CD11c promoter. A single administration of DT to these mice allowed the specificity and timing of CD11c high cDCs ablation in vivo [14] . Hepatic
DCs are poised to orchestrate immune responses in a way that maintains tolerance to self [15] and be activated to induce T cell activation, cytokine and chemokine-mediated immune responses. DCs from healthy liver exhibit a decreased ability to capture antigens and stimulate T cells; they are also reported to be less immunogenic than their splenic counterparts [16] and produce increased interleukin (IL)-10 [17] , which might help to maintain allograft survival after liver transplantation. Lines of evidence suggest that hepatic DCs play a regulatory role in murine liver disease models. Using CD11c-DTR Tg mice, Bamboat et al. reported that during ischaemia/reperfusion (I/R), production of IL-10 by cDCs suppressed inflammatory monocyte function and reduced liver injury [18] . cDC depletion in DTR mice also exacerbates acetaminophen (APAP) hepatotoxicity in a manner independent of neutrophils, NK cells or inflammatory mediators [19] . However, whether or not cDCs are involved in ConA-mediated hepatitis, especially the regulation of NK T or CD4 1 T cells, has not been investigated. IL-12 is composed of two subunits, namely p35 and p40, and secreted by a series of haematopoietic cells, mainly antigen-presenting cells (APCs) such as DCs and macrophages [20] . It binds to its receptor composed of IL-12Rb1 and IL-12Rb2 chains expressed on activated T cells, NK, NK T cells and DCs. Physiological responses to IL-12 are mediated mainly through Janus-associated kinase 2 (Jak2), tyrosine kinase 2 (Tyk2) and signal transducer and activator of transcription (STAT), especially STAT-4 [20, 21] . The central role of IL-12 is to induce the T helper type 1 (Th1) response. IL-12 can promote the differentiation of naive T cells towards Th1 cells that enable them to produce IFN-g [22] . In response to a-galactosylceramide (a-GalCer), NK T cells expressed IFN-g, which also required direct contact with DC and IL-12 production by DCs [23] . In hepatitis, neutralizing IL-12 could diminish IFN-g in serum and alanine aminotransferase (ALT) levels [24] . Blockade of IL-12 activity leads to loss of early IFN-g production IL-12 in mice infected with Leishmania major [25] . IL-12-induced IFN-g also plays a critical part in the control of tumour growth [26] .
In this study, we investigated the role of cDCs in T cellmediated acute liver injury. Using a model of ConA-induced fulminant hepatitis in transgenic CD11c-diphtheria toxin receptor (DTR) mice, we observed that upon DT treatment, DTR mice were highly protected against ConA-induced hepatitis, and we elucidated further the underlying mechanisms of cDC-derived IL-12 in promoting IFN-g production by NK T cells. Our experiment showed that interventions of DC or IL-12 may be a potential therapy for hepatitis.
Materials and methods

Mice
C57BL/6J (B6) wild-type (wt) mice were purchased from the Academy of Military Medical Science (Beijing, China). B6.FVB-Tg [integrin subunit alpha X (Itgax)-DTR/ enhanced green fluorescent protein (EGFP)] and 57Lan/J (B6 CD11c-DTR) mice were purchased from The Jackson Laboratory (Bar Harbor, ME, USA). CD1d -/-mice were kindly provided by Professor Li Bai (University of Science and Technology of China, Hefei, China). All experimental mice were maintained in a specific pathogen-free facility at Nankai University (Tianjin, China) and used when they were 6-8 weeks old. All experiments were performed in accordance with guidelines for animal care, created by the Nankai University Experimental Animal Ethics Committee.
Reagents
ConA (type IV) was purchased from Sigma-Aldrich (St Louis, MO, USA). Recombinant mouse (rm) granulocytemacrophage colony-stimulating factor (GM-CSF) and rmIL-4 were purchased from PeproTech (London, UK 
T cell-mediated hepatitis model
To induce hepatitis, we injected wt and DTR mice by intravenous injection (i.v.) with 10 mg/kg ConA from our laboratory, as described previously [7] . The dose was increased to 25 mg/kg body weight to study the survival rate.
Assay for serum transaminase activity
Mice blood samples were obtained at different time-points after ConA injection, maintained at room temperature for 2 h, followed by centrifugation at 2516 g for 8 min to separate the serum. Serum ALT activities were measured using an ALT test kit (Rong Sheng Biotech, Shanghai, China), according to the manufacturer's protocol.
Liver mononuclear cell preparation
Liver mononuclear cells were isolated by centrifugation in a Percoll gradient, as described previously [7] . 
Flow cytometry
In-vivo cell depletion
For depletion of cDCs, mice were i.p. injected with DT (4 ng/g body weight) 24 h before ConA treatment. In our preliminary experiments, the depletion of cDCs was more than 90% and lasted for 36 h. For depletion of NK1.1 
Adoptive transfer of liver MNCs
The recipient mice were treated with anti-NK1.1 monoclonal antibody (mAb) 72 and 48 h before adoptive transfer to deplete NK and NK T cells while not affecting the transferred mononuclear cells (MNCs) [27] . Under isoflurane anaesthesia, hepatic MNCs (5 3 10 6 cells) suspended in 30 ll PBS were injected into the lateral left lobe of the liver using a 1-ml insulin syringe (BD Biosciences, Franklin Lakes, New Jersey, USA), as described previously [28] .
Enzyme-linked immunosorbent assay (ELISA)
Mouse IL-12, IFN-g, tumour necrosis factor (TNF)-a, IL-4, IL-17 and IL-10 ELISA kits were purchased from (BioLegend) and ELISA was performed according to the manufacturer's protocol.
Real-time polymerase chain reaction (PCR)
Total RNA of liver monocular cells or sorted cells was extracted by TRIzol reagent (Invitrogen, Carlsbad, CA, USA). RNA was reverse-transcribed using Tiangen reverse transcription reagent (Sungene Biotech). RNA expression was quantified by real-time PCR. SYBR PreMix HotMaster Taq (Sungene Biotech) was used in real-time PCR on a Mastercyclerep Realplex (Eppendorf, Hamburg, Germany). Results represent the relative expression level normalized against glyceraldehyde 3-phosphate dehydrogenase (GAPDH). Mouse genes were amplified by the following primers: T-bet, 5
The results were analysed by Realplex software (version 5.01 for Windows. *P < 0Á05, **P < 0Á01 and ***P < 0Á001 were used to show statistical significance throughout the text, figures and legends.
Results
Liver cDC depletion alleviates ConA-induced fulminant hepatitis
To investigate the role of cDCs in hepatitis, age-and sexmatched B6 wt and CD11c-DTR Tg mice were used. As expected, based on prior studies [14, 18, 19, 29] , a single injection of DT depleted approximately 90% of hepatic cDCs in CD11c-DTR mice (Fig. 1a) . Meanwhile, DT did not show any toxic effect to wt mice (data not shown). We then challenged sex-and age-matched DT-treated B6 wt and DTR mice with lethal doses of ConA (25 mg/kg) and survival rates of mice were observed and recorded. Surprisingly, in comparison with B6 wt mice, all DTR mice survived for 72 h (Fig. 1b) ,
indicating an important role of cDCs in ConA-induced liver damage. We then used lower concentrations of ConA in our experimental system to elucidate the mechanisms as titrated previously in our laboratory. Therefore, unless mentioned specifically, we used a low dose (10 mg/kg) of ConA for experiments in this study. Less severe hepatitis appeared in DTR mice than those in wt mice, as indicated by the serum ALT level (Fig. 1c) . This was evidenced further by liver histopathology at 12 h after treatment of ConA. Significantly large areas of necrosis in liver tissues were observed in wt mice, while no visible histological changes were found in DTR mice (Fig. 1e) . To define further the role of DCs in ConA-induced hepatitis, B6 wt mice were administered anti-CD11c antibodies, as described in Materials and methods. In our preliminary studies, this approach resulted in 95% of depletion of CD11c 1 cells and lasted for 72 h. Depletion of CD11c 1 DCs reduced hepatitis serum ALT significantly (Fig. 1d) . Histological evaluation of the liver tissues after 12 h of ConA was consistent with serum ALT results, and wt mice displayed larger percentages of hepatocyte necrosis than those of CD11c cell-depleted mice (Fig. 1e,f) . These results demonstrate collectively a proinflammation role of cDCs in the ConA-induced hepatitis model.
Characterization of cDCs in the liver during ConAinduced hepatitis
To define the characterization of cDCs (CD11c high MHC class II 1 ) after hepatic injury, liver NPCs were isolated from liver at different time points post ConA treatment (0, 2, 6, 12 and 18 h). We showed that during the early stages of ConA induced hepatitis, the absolute number and percentage of cDCs decreased; however, the number increased from the time-points of 6 h and later (Fig. 2a) . Interestingly, a significant correlation was observed between the frequency of cDCs in the liver and ALT levels (Fig. 2b) . Consistent with previous work by Bamboat et al. [18] , the remaining cDCs in the liver were mature, with increased expressions of CD40, CD80 and CD86 (Fig. 2c) . These suggested collectively that there is a significant correlation between cDCs and ConA-induced hepatitis.
cDCs deficiency reduces the inflammatory cytokine storms upon ConA treatment
Various cytokines are involved in the pathogenesis of ConAinduced hepatitis. To define the mechanisms of decreased liver injury in CD11c-DTR Tg mice, the inflammation cytokine levels were analysed in serum samples collected at different time-points post-ConA challenge. A remarkable cytokine storm was observed in wt mice upon ConA treatment. Notably, compared to wt mice, extremely decreased levels of IFN-g, TNF-a, IL-4 and IL-12 in DTR mice were observed during 2-12 h upon ConA administration (Fig. 3) . Interestingly, levels of IL-10 and IL-17 showed no significant changes upon cDC depletion. These results demonstrate collectively the role of cDCs in regulating inflammatory cytokine production in ConA-mediated hepatitis.
cDC deficiency leads to decreased IL-12 levels in DTR mice
To test the hypothesis that cDCs might be an important source of IL-12, liver lymphocytes were isolated from wt and DTR mice at 2 h post-ConA treatment and an array of cytokines were analysed by real-time PCR. Consistently, reduced expressions of IL-12 p40, IL-12 receptor b and Tbet were found in DTR mice; no significant changes were observed between these groups of mice for IL-17 (Fig. 4a) (Fig. 4b) . To test our hypothesis further, we directly examined cytokine expression of cDCs upon ConA treatment. Indeed, expression levels of IL-12 p35 and p40 in cDCs was increased significantly, whereas no dramatic differences were seen in the expression levels of IL-4 and IL-10 ( Fig. 4c) . These results indicated that cDCs were the main source of IL-12 in this model of acute liver injury.
Essential role of IL-12 in mediating IFN-g production of NK T cells in hepatitis
To test the role of IL-12 in the pathogenesis of acute liver injury, sex-and age-matched B6 wt and DTR mice were treated with DT as mentioned above, then these mice were treated with i.p. injections of either 400 ng rmIL-12 or PBS followed by ConA injection. Liver lymphocytes were prepared 2 h post-ConA treatment. IFN-g secretion by NK T and CD4 1 T cells was analysed by flow cytometry. Upon DT treatment, numbers of IFN-g-producing NK T cells decreased significantly, however, without affecting those of CD4 1 T cells (Fig. 5a) . Administration of IL-12 recovered the IFN-g secretion fully only by NK T cells, but not from CD4 1 T cells (Fig. 5a,b) . We next tested further the effect of IL-12 in ConA-induced hepatitis; sex-and age-matched B6 wt were treated with or without anti-IL-12 and DTR mice were treated with DT as above, followed with IL-12 only, or IL-12 plus anti-NK1.1 antibodies. NK1.1 antibody depleted NK and NK T cells efficiently (Fig. 5c) . Treatment with anti-IL-12 impaired ConA-induced hepatitis significantly (Fig. 5d) , confirming the role of IL-12 in the pathogenesis of acute liver injury. Interestingly, administration of IL-12 to DT-treated DTR mice reconstitute the ConAinduced hepatitis significantly, whereas depletion of NK T cells using NK1.1 antibodies neutralized the phenotype, indicating strongly the effect of IL-12 on NK T cells (Fig.  5d) . These results were confirmed further by liver (Fig. 5e,f) . NK1.1 antibody also depleted NK cells (Fig. 5c) ; to exclude the possibility that NK cells in the liver are involved in this reaction, CD1d
-/-mice were used. DTR mice were treated with DT, IL-12 and anti-NK1.1 antibody, then liver MNCs from wt mice or CD1d -/-mice were transferred to these mice. Hepatic MNCs from wt but not CD1d -/-mice could mediate liver injury in these mice, shown by significantly increased serum ALT levels ( Fig. 5g ) and bigger necrosis areas (Fig.  5h,i) , suggesting that NK T cells were the target of IL-12 in hepatitis.
Discussion
Acute liver failure is a devastating liver disease with significant mortality and without an effective therapeutic approach. ConA-induced fulminant hepatitis is a well-used model for studying the pathophysiology mechanisms of acute liver injury [6] . DCs have been well defined in orchestrating both innate and adaptive immunity [30, 31] ; however, the role of DC in ConA-induced hepatitis has been elusive. In this report we demonstrated for the first time, to our knowledge, that DCs, especially cDCs, played a detrimental role in ConA-induced liver injury through IL-12 production which, in turn, regulates NK T cell function, especially the production of IFN-g.
One of the key findings in our study is establishing for the first time, to our knowledge, a unique role of cDCs in ConA-induced hepatitis. DCs are not only the primary APCs, but also regulate immune response through secreting an array of inflammatory cytokines [32] [33] [34] [35] [36] . However, the role of DCs in acute liver injury has not yet been reported. Using either CD11c-DTR Tg mice or anti-CD11c antibodies to deplete CD11c
1 DCs, we demonstrated collectively that DCs played a detrimental role in promoting ConA-induced liver injury (Fig. 1) . DCs have many subsets, with divergent functions [30, 31, [36] [37] [38] . Administration of DT depletes CD11c high MHC class II 1 conventional DCs (cDCs) selectively (Fig. 1a) , indicating a predominant role of this subset in increasing the susceptibility of ConAinduced acute hepatitis. It has to be emphasized that the role of other subsets of DCs, such as pDC, which produce predominantly IFN-a [39, 40] , remains to be studied further.
We next addressed the question concerning how cDCs mediated the ConA-induced liver injury. We hypothesized that these cDCs would act through producing cytokines. Indeed, our study established firmly that it was IL-12 deriving from cDCs that played a critical role in mediating the detrimental role in ConA-induced acute hepatitis. (Fig. 5c) . Finally, administration of recombinant IL-12 into DTtreated DTR Tg mice showed that these mice regained susceptibility (Fig. 5c) . Our results thus define a critical role of cDCs in providing the source of IL-12 in ConAinduced hepatitis.
One of the essential functions of IL-12 is inducing IFNg production by a few cell types, including CD4 1 T cells, NK and T cells [22, 41, 42] . We wished to determine the ability of NKT cells to produce IFN-g after concanavalin A (ConA) treatment was abolished in CD11c-diphtheria toxin receptor transgenic (DTR Tg) mice, which can be restored by IL-12 reconstitution. Sex and age-matched C57BL/6 wild-type (wt) and CD11c-DTR Tg mice were treated with diphtheria toxin (DT) as mentioned above, then these mice (n 5 source of IFN-g induced by IL-12 in the ConA-induced hepatitis model. Although our previous studies revealed that IFN-g produced by either CD4 1 T cells or NK T cells was involved in the pathogenesis of ConA-induced liver injury depending the immune environment [7, 8] , interestingly, we provided solid evidence that DC-derived IL-12 triggered only NK T cells producing IFN-g, without affecting the function of CD4 1 T cells (Fig. 5a,b) . This conclusion was supported with results obtained from in-vivo studies, with either reconstitution with IL-12 in DTR mice or depletion of NK T cells in IL-12 treated DTR mice ( Fig.  5d-f ). In addition, adoptively transferred liver MNCs from wt but not CD1d -/-mice to IL-12 and anti-NK1.1 antibody-treated DTR mice confirmed further that NK T cells are the target of IL-12 in hepatitis, excluding the possibility that NK cells are involved in the reaction (Fig. 5g-i) . We do not yet understand fully the underlying mechanisms of why DC-derived IL-12 in this special circumstance acts on only NK T cells. One possibility is the differential threshold of activation between CD4
1 T cells and NK T cells, with a better response of NK T cells to lower concentrations of IL-12. Other possibilities might include the response to other ConA or ConA-induced signalling pathways. Further studies are needed to clarify the matter and it would lead to clearer understanding of the pathogenesis of this model. Therefore, our results established the detrimental role of cDCs in T cell-dependent hepatitis. cDCs are the critical source of IL-12, and IL-12 can target NK T cells to regulate their IFN-g production, a mechanism different from other liver injury models mentioned above. Our finding could also shed light upon developing novel therapeutic approaches targeting cDCs in hepatitis.
